A web-based interactive tool to explore antibiotic resistance and consumption via maps and charts

Transcription

1 A web-based interactive tool to explore antibiotic resistance and consumption via maps and charts

2 CDDEP first developed ResistanceMap in 21. The new ResistanceMap now includes more countries with up-to-date antibiotic resistance and use data. It includes: Antibiotic use data for 69 countries (new for all countries except the US) Antibiotic resistance data for 44 countries. New countries added include South Africa, India, Thailand, Vietnam, Kenya, Australia, Belarus, Macedonia, Serbia, Switzerland, Turkey and New Zealand. Data from other LMICs the Philippines, Nepal and Mozambique and one upper-middle income country, China, will be added soon.

3 Three types of graphic options: Maps Trends Charts World maps allow comparisons of use or resistance across countries for the latest year. Sub-national maps allow comparisons of use or resistance across regions or states for the latest year. Trends allow exploration of use or resistance for a country over time. Charts allow comparisons of use or resistance between countries for the latest year.

4 Select map, trend or chart. The landing view on the resistance section displays a map with the most recent resistance data. By default, E. coli s resistance is displayed. Click on a pathogen to explore its resistance. Antibiotics that have resistance data available are displayed in black. Antibiotic whose data is currently displayed is highlighted in blue.

5 In 213, carbapenem-resistant E.coli was reported in 26 countries Highest in India (11%), followed by Vietnam (9%) and Bulgaria (3%) Not detected in eight countries Croatia, Finland, Latvia, Lithuania, Luxembourg, Poland, Romania and Slovakia

6 In 213, third-generation cephalosporin-resistant E. coli was reported in 35 countries Lowest in Iceland (5%) and highest in India (8%)

7 In 213, fluoroquinolone-resistant E. coli was reported in 35 countries Lowest in Australia (1%) and highest in (India 85%)

8 In 213, carbapenem-resistant K. pneumoniae was reported in 28 countries Highest in Greece (6%), followed by India (6%) and Italy (36%) Not detected in six countries Bulgaria, Finland, Latvia, Lithuania, New Zealand and Sweden

9 In 213, third-generation cephalosporin-resistant K. pneumoniae was reported in 35 countries Lowest in Iceland (%) and highest in India (85%)

10 In 213, fluoroquinolone-resistant K. pneumoniae was reported in 34 countries Lowest in Australia (5%) and highest in India (8%)

11 In 213, carbapenem-resistant P. aeruginosa was reported in 29 countries Highest in Romania (63%), followed by Slovakia (63%) and Greece (54%)

12 In 213, ceftazidime-resistant P. aeruginosa was reported in 29 countries Highest in India (53%), followed by Romania (5%) and Greece (39%) Lowest in Denmark (4%)

13 6 4 2 In 213, uoroquinolone-resistant P. aeruginosa was reported in 28 countries Highest in India (55%), followed by Slovakia (55%) and Romania (49%) Lowest in Denmark (4%)

14 In 213, methicillin-resistant S. aureus (MRSA) was reported in 33 countries Highest in Romania (65%), followed by Malta (52%) and Portugal (47%) Lowest in Iceland (%)

15 In 213, aminopenicillin-resistant E. faecalis was reported in 27 countries Highest in Lithuania (28%), followed by Estonia (24%) and India (12%) Not detected in Australia, Cyprus, Malta, Slovenia and Sweden

16 In 213, vancomycin-resistant E. faecium was reported in 28 countries Highest in Ireland (43%), followed by Australia (41%) and Cyprus (23%) Not detected in Estonia and Sweden

17 6 4 2 In 213, penicillin-resistant S. pneumoniae was reported in 25 countries Highest in ailand (39%), followed by Poland (32%) and Spain (3%) Lowest reported in the Netherlands (1%)

18 Select map, trend or chart. Std Units/ 1 Pop The landing view on the use section displays a map with 21 antibiotic use data. Hovering above a country displays its data. Select antibiotics to display their use rates.

19 Std Units/ 1 Pop 4k 3k 2k 1k k Source: IMS Health Use of all antibiotics in 21 Between 2 and 21, antibiotic use increased by more than 3% Brazil, Russia, India, China and South Africa accounted for about three-quarters of this increase

20 Std Units/ 1 Pop Source: IMS Health Use of carbapenems in 21 Between 2 and 21, carbapenem use increased in 57 countries In 21, Japan had the highest per capita consumption of carbapenems

21 Std Units/ 1 Pop Source: IMS Health Use of polymyxins in 21 Between 2 and 21, polymyxin use increased in 33 countries In 21, Ireland had the highest per capita consumption of polymyxins